Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126389521 | 12638952 | 1 | I | 20160524 | 20160527 | 20160809 | 20160809 | EXP | ES-ABBVIE-16P-144-1641275-00 | ABBVIE | 60.66 | YR | F | Y | 60.00000 | KG | 20160809 | CN | COUNTRY NOT SPECIFIED | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126389521 | 12638952 | 1 | PS | VIEKIRAX | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | N | 1056301,1059373 | 207931 | 2 | DF | TABLET | QD | |||||
| 126389521 | 12638952 | 2 | SS | REBETOL | RIBAVIRIN | 1 | Oral | 2-0-3 | N | 5RCJA93A05 | 0 | TABLET | Q12H | ||||||
| 126389521 | 12638952 | 3 | SS | REBETOL | RIBAVIRIN | 1 | Oral | 2-0-2 | N | 5RCJA93A05 | 0 | 400 | MG | TABLET | Q12H | ||||
| 126389521 | 12638952 | 4 | SS | REBETOL | RIBAVIRIN | 1 | Oral | N | 5RCJA93A05 | 0 | 250 | MG | TABLET | Q12H | |||||
| 126389521 | 12638952 | 5 | C | SECALIP SUPRA | 2 | Oral | 0 | QD | |||||||||||
| 126389521 | 12638952 | 6 | C | OMEPRAZOL | OMEPRAZOLE | 1 | Oral | 0 | |||||||||||
| 126389521 | 12638952 | 7 | C | METFORMINE | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | BID | ||||||||||
| 126389521 | 12638952 | 8 | C | ORFIDAL | LORAZEPAM | 1 | Oral | 1 TABLET WHEN THE PATIENT WENTO TO BED | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126389521 | 12638952 | 1 | Hepatitis C |
| 126389521 | 12638952 | 2 | Hepatitis C |
| 126389521 | 12638952 | 5 | Hypercholesterolaemia |
| 126389521 | 12638952 | 6 | Product used for unknown indication |
| 126389521 | 12638952 | 7 | Diabetes mellitus |
| 126389521 | 12638952 | 8 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126389521 | 12638952 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126389521 | 12638952 | Abdominal discomfort | |
| 126389521 | 12638952 | Anaemia | |
| 126389521 | 12638952 | Atrophy | |
| 126389521 | 12638952 | Dizziness | |
| 126389521 | 12638952 | Drug reaction with eosinophilia and systemic symptoms | |
| 126389521 | 12638952 | Faeces discoloured | |
| 126389521 | 12638952 | Faeces soft | |
| 126389521 | 12638952 | Fatigue | |
| 126389521 | 12638952 | Feeling abnormal | |
| 126389521 | 12638952 | Gastric neoplasm | |
| 126389521 | 12638952 | Hepatic neoplasm | |
| 126389521 | 12638952 | Jaundice | |
| 126389521 | 12638952 | Pancreatic neoplasm | |
| 126389521 | 12638952 | Pruritus | |
| 126389521 | 12638952 | Vascular neoplasm |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126389521 | 12638952 | 1 | 20160524 | 20160728 | 0 | |
| 126389521 | 12638952 | 2 | 20160524 | 20160614 | 0 | |
| 126389521 | 12638952 | 3 | 20160614 | 0 | ||
| 126389521 | 12638952 | 4 | 20160728 | 0 |